Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Raloxifene and body composition and muscle strength in postmenopausal women: A randomized, double-blind, placebo-controlled trial
European Journal of Endocrinology, 11/05/09
Jacobsen D et al. – The aim was to compare the effects of raloxifene and placebo on body composition and muscle strength. Raloxifene significantly changed (increased fat–free mass; increased water content) body composition compared with placebo in postmenopausal women.
Related Articles
Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Annals of Internal Medicine, 11/17/09
Relevance Score: 87%
Benefits and risks of raloxifene by vertebral fracture status
Current Medical Research and Opinion, 11/13/09
Relevance Score: 87%
Effects of raloxifene on the renin–angiotensin–aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women
Geriatrics and Gerontology International, 10/12/09
Relevance Score: 87%
Raloxifene: its ossification-promoting effect on female mesenchymal stem cells
Journal of Orthopaedic Science, 10/08/09
Relevance Score: 87%
Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass
Osteoporosis International, 10/06/09
Relevance Score: 85%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Today in Women`s Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Extremes of Endogenous Testosterone Are Associated with Increased Risk of Incident Coronary Events in Older Women
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Cardiac Stress Testing in Women
The Journal for Nurse Practitioners , 11/25/09
Diabetes Mellitus and Sexuality - Does it Really Matter?
The Journal of Sexual Medicine, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


